CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133679168
- Phone
- 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +63,775 | $0.03 | $2K | 93,189,560 |
| 2025-01-30 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +100,003 | $0.03 | $3K | 93,125,785 |
| 2025-01-29 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +183,066 | $0.03 | $5K | 93,025,782 |
| 2024-11-22 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +298,499 | $0.03 | $9K | 92,842,716 |
| 2024-08-23 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +500,000 | $0.02 | $10K | 92,544,217 |
| 2023-06-29 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +425,000 | $0.02 | $9K | 92,044,217 |
| 2023-06-28 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +75,000 | $0.03 | $2K | 91,619,217 |
| 2023-06-16 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +100,000 | $0.03 | $3K | 91,544,217 |
| 2023-06-14 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +400,000 | $0.03 | $13K | 91,444,217 |
| 2023-05-26 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +126,888 | $0.03 | $4K | 91,044,217 |
| 2023-05-02 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +100,000 | $0.05 | $5K | 90,917,329 |
| 2022-12-06 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +120,000 | $0.05 | $6K | 90,558,021 |
| 2022-11-22 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +70,000 | $0.08 | $6K | 90,438,021 |
| 2022-09-26 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +20,000 | $0.07 | $1K | 90,368,021 |
| 2022-08-25 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +80,000 | $0.08 | $7K | 90,348,021 |
| 2021-09-03 | Trieu Vuong Chief Executive Officer | Grant or award · Stock Options | +225,000 | 225,000 | ||
| 2021-09-03 | MAIDA ANTHONY E III Chief Clin. Ops. Officer | Grant or award · Stock Options | +600,000 | 600,000 | ||
| 2021-09-03 | KING STEVEN W Director | Grant or award · Stock Options | +500,000 | 500,000 | ||
| 2021-09-03 | Saund Saran Chief Business Officer | Grant or award · Stock Options | +675,000 | 675,000 | ||
| 2021-07-08 | MAIDA ANTHONY E III CHIEF CLINICAL OFFICER | Grant or award · Stock Options | +400,000 | 400,000 |
Page 2 of 7 · 140 trades